Sign Up to like & get
recommendations!
1
Published in 2020 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-020-05381-5
Abstract: We present the first detailed report of acneiform eruptions in patients on CTLA-4 inhibitor therapy. Acneiform eruptions commonly occur (up to 75–100%) as a cutaneous adverse event associated with EGFR inhibition; however, acneiform eruptions have…
read more here.
Keywords:
ctla inhibitor;
inhibitor therapy;
acneiform eruptions;
cutaneous adverse ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Biomedicines"
DOI: 10.3390/biomedicines6010026
Abstract: Targeting the immune checkpoint receptors cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1), or programmed cell death 1 ligand 1 (PD-L1) represents a very attractive treatment modality for tumor patients. The…
read more here.
Keywords:
ctla inhibitor;
prior ctla;
inhibitor;
treatment ... See more keywords